Screening for Cystic Fibrosis Related Complications in the Context of a Pandemic and Altered Models of Care

Overview

Journal Health Serv Insights

Publisher Sage Publications

Specialty Health Services

Date 2023 Oct 19

PMID 37854074

Authors

Michael Doumit

Roxanne Strachan

Raynuka Lazarus

Peter Middleton

Ruth Dentice

Jessica Marouvo

Laura Jeffrey

Hiran Selvadurai

Sheila Sivam

Verity Pacey

Adam Jaffe

Kelly Gray

Affiliations

Soon will be listed here.

Abstract

Background: Standard of care recommend that patients with cystic fibrosis (CF) require screening investigations to assess for complications. Changing models of care due to the COVID19 pandemic may have impacted completion of recommended screening.

Objective: To compare the frequency of screening investigations completed in people with CF before and after the onset of the COVID19 pandemic.

Methods: Medical records were reviewed at 4 CF-specialist centers to identify screening investigations completed in the 12-months before and after pandemic onset.

Results: Records of 625 patients were reviewed. Prior to pandemic onset, there was between center variability in completion of screening investigations. There was greatest baseline variation between centers in performing oral glucose tolerance test (OGTT); range 38%-69%, exercise tests; 3%-51% and sputum screening for non-tuberculous mycobacteria; 53%-81%. Following pandemic onset, blood tests, and sputum cultures were maintained at the highest rates. Exercise testing, CXR and OGTT exhibited the greatest declines, with reductions at individual centers ranging between 10%-24%, 22%-43%, and 20%-26%, respectively. Return to in-person visits following pandemic onset was variable, ranging from 16% to 74% between centers.

Conclusion: Completion of screening investigations varies between CF centers and changes in models of care, such as increased virtual care in response to COVID19 pandemic was associated with reduction in completion of investigations. Centers would benefit from auditing their adherence to standards of care, particularly considering recent changes in care delivery.

References

Doumit M, Chuang S, Middleton P, Selvadurai H, Sivam S, Ruseckaite R . Clinical outcomes of adults and children with cystic fibrosis during the COVID-19 pandemic. J Cyst Fibros. 2022; 22(3):581-586. PMC: 9477965. DOI: 10.1016/j.jcf.2022.09.006. View

Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W . Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009; 32(9):1626-31. PMC: 2732133. DOI: 10.2337/dc09-0586. View

Long J, Dixon M, Sharma V, Patel L, David T . Annual review hospital visits for patients with cystic fibrosis. J R Soc Med. 2001; 94 Suppl 40:12-6. PMC: 1310580. DOI: 10.1177/014107680109440s05. View

Tejero Garcia S, Giraldez Sanchez M, Cejudo P, Gallego E, Dapena J, Garcia Jimenez R . Bone health, daily physical activity, and exercise tolerance in patients with cystic fibrosis. Chest. 2011; 140(2):475-481. DOI: 10.1378/chest.10-1508. View

Jaffe A, Buchdahl R, Bush A, Balfour-Lynn I . Are annual blood tests in preschool cystic fibrosis patients worthwhile?. Arch Dis Child. 2002; 87(6):518-20. PMC: 1755836. DOI: 10.1136/adc.87.6.518. View

Chuang S, Doumit M, McDonald R, Hennessy E, Katz T, Jaffe A . Annual Review Clinic improves care in children with cystic fibrosis. J Cyst Fibros. 2013; 13(2):186-9. DOI: 10.1016/j.jcf.2013.09.001. View

Mahadeva R, Webb K, Westerbeek R, Carroll N, Dodd M, Bilton D . Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998; 316(7147):1771-5. PMC: 28574. DOI: 10.1136/bmj.316.7147.1771. View

Jaclyn D, Andrew N, Ryan P, Julianna B, Christopher S, Nauman C . Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19. J Cyst Fibros. 2021; 20(3):e23-e28. PMC: 7997421. DOI: 10.1016/j.jcf.2021.03.009. View

Portaccio E, Fonderico M, Hemmer B, Derfuss T, Stankoff B, Selmaj K . Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey. Mult Scler. 2021; 28(1):132-138. PMC: 8689421. DOI: 10.1177/13524585211005339. View

10.

Dowd C, Van Citters A, Dieni O, Willis A, Powell L, Sabadosa K . Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic. J Cyst Fibros. 2021; 20 Suppl 3:3-8. PMC: 8683121. DOI: 10.1016/j.jcf.2021.08.028. View

11.

Carr S, Dinwiddie R . Annual review or continuous assessment?. J R Soc Med. 1996; 89 Suppl 27:3-7. PMC: 1295618. View

12.

Van Citters A, Dieni O, Scalia P, Dowd C, Sabadosa K, Fliege J . Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team members. J Cyst Fibros. 2021; 20 Suppl 3:23-28. PMC: 8683122. DOI: 10.1016/j.jcf.2021.09.004. View

13.

Fotheringham P, Anderson T, Shaw M, Jewitt J, Storey H, Hutchings O . Control of COVID-19 in Australia through quarantine: the role of special health accommodation (SHA) in New South Wales, Australia. BMC Public Health. 2021; 21(1):225. PMC: 7838858. DOI: 10.1186/s12889-021-10244-7. View

14.

Stone E, Irving L, Tonga K, Thompson B . Sustaining the Australian respiratory workforce through the COVID-19 pandemic: a scoping literature review. Intern Med J. 2022; 52(7):1115-1122. PMC: 9111702. DOI: 10.1111/imj.15718. View

15.

Cobo-Calvo A, Zabalza A, Rio J, Arrambide G, Otero-Romero S, Tagliani P . Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre. J Neurol. 2022; 269(4):1764-1772. PMC: 8743162. DOI: 10.1007/s00415-021-10958-z. View

16.

Yankaskas J, Marshall B, Sufian B, Simon R, Rodman D . Cystic fibrosis adult care: consensus conference report. Chest. 2004; 125(1 Suppl):1S-39S. DOI: 10.1378/chest.125.1_suppl.1s. View

17.

Haworth C, Jones A, Adams J, Selby P, Webb A . Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. J Cyst Fibros. 2005; 3(4):233-6. DOI: 10.1016/j.jcf.2004.08.002. View

18.

Saibeni S, Scucchi L, Dragoni G, Bezzio C, Miranda A, Ribaldone D . Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. United European Gastroenterol J. 2020; 8(10):1228-1235. PMC: 7724532. DOI: 10.1177/2050640620964132. View

19.

Collaco J, Albon D, Ostrenga J, Flume P, Schechter M, Cromwell E . Factors associated with receiving CF care and use of telehealth in 2020 among persons with Cystic Fibrosis in the United States. J Cyst Fibros. 2022; 22(3):456-463. DOI: 10.1016/j.jcf.2022.12.004. View

20.

Solomon G, Bailey J, Lawlor J, Scalia P, Sawicki G, Dowd C . Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic. J Cyst Fibros. 2021; 20 Suppl 3:41-46. PMC: 8683126. DOI: 10.1016/j.jcf.2021.09.005. View